INTRODUCTION: Human sulfatase 1 (SULF1) was recently identified and shown to desulfate cellular heparan sulfate proteoglycans (HSPGs). Since sulfated HSPGs serve as co-receptors for many growth factors and cytokines, SULF1 was predicted to modulate growth factor and cytokine signaling. DISCUSSION: The role of SULF1 in growth factor signaling and its effects on human tumorigenesis are under active investigation. Initial results show that SULF1 inhibits the co-receptor function of HSPGs in multiple receptor tyrosine kinase signaling pathways, particularly by the heparin binding growth factors--fibroblast growth factor 2, vascular endothelial growth factor, hepatocyte growth factor, PDGF, and heparin-binding epidermal growth factor (HB-EGF). SULF1 is downregulated in the majority of cancer cell lines examined, and forced expression of SULF1 decreases cell proliferation, migration, and invasion. SULF1 also promotes drug-induced apoptosis of cancer cells in vitro and inhibits tumorigenesis and angiogenesis in vivo. CONCLUSION: Strategies targeting SULF1 or the interaction between SULF1 and the related sulfatase 2 will potentially be important in developing novel cancer therapies.
INTRODUCTION:Humansulfatase 1 (SULF1) was recently identified and shown to desulfate cellular heparan sulfate proteoglycans (HSPGs). Since sulfated HSPGs serve as co-receptors for many growth factors and cytokines, SULF1 was predicted to modulate growth factor and cytokine signaling. DISCUSSION: The role of SULF1 in growth factor signaling and its effects on humantumorigenesis are under active investigation. Initial results show that SULF1 inhibits the co-receptor function of HSPGs in multiple receptor tyrosine kinase signaling pathways, particularly by the heparin binding growth factors--fibroblast growth factor 2, vascular endothelial growth factor, hepatocyte growth factor, PDGF, and heparin-binding epidermal growth factor (HB-EGF). SULF1 is downregulated in the majority of cancer cell lines examined, and forced expression of SULF1 decreases cell proliferation, migration, and invasion. SULF1 also promotes drug-induced apoptosis of cancer cells in vitro and inhibits tumorigenesis and angiogenesis in vivo. CONCLUSION: Strategies targeting SULF1 or the interaction between SULF1 and the related sulfatase 2 will potentially be important in developing novel cancer therapies.
Authors: R Kikuno; T Nagase; K Ishikawa; M Hirosawa; N Miyajima; A Tanaka; H Kotani; N Nomura; O Ohara Journal: DNA Res Date: 1999-06-30 Impact factor: 4.458
Authors: H D Soule; T M Maloney; S R Wolman; W D Peterson; R Brenz; C M McGrath; J Russo; R J Pauley; R F Jones; S C Brooks Journal: Cancer Res Date: 1990-09-15 Impact factor: 12.701
Authors: E Galeazzi; M Olivero; F C Gervasio; A De Stefani; G Valente; P M Comoglio; M F Di Renzo; G Cortesina Journal: Eur Arch Otorhinolaryngol Date: 1997 Impact factor: 2.503
Authors: Junsheng Li; Jörg Kleeff; Ivane Abiatari; Hany Kayed; Nathalia A Giese; Klaus Felix; Thomas Giese; Markus W Büchler; Helmut Friess Journal: Mol Cancer Date: 2005-04-07 Impact factor: 27.401
Authors: Jin-Ping Lai; Abdul M Oseini; Catherine D Moser; Chunrong Yu; Sherine F Elsawa; Chunling Hu; Ikuo Nakamura; Tao Han; Ileana Aderca; Hajime Isomoto; Megan M Garrity-Park; Abdirashid M Shire; Jia Li; Schuyler O Sanderson; Alex A Adjei; Martin E Fernandez-Zapico; Lewis R Roberts Journal: Hepatology Date: 2010-11 Impact factor: 17.425
Authors: Jonathan P Butchar; Donna Cain; Sathiya N Manivannan; Andrea D McCue; Liana Bonanno; Sarah Halula; Sharon Truesdell; Christina L Austin; Thomas L Jacobsen; Amanda Simcox Journal: Genetics Date: 2012-05-17 Impact factor: 4.562
Authors: Cathelijn J F Waaijer; Carlos E de Andrea; Andrew Hamilton; Jolieke G van Oosterwijk; Sally E Stringer; Judith V M G Bovée Journal: Virchows Arch Date: 2012-08-18 Impact factor: 4.064
Authors: J H Kim; C Chan; C Elwell; M S Singer; T Dierks; H Lemjabbar-Alaoui; S D Rosen; J N Engel Journal: Cell Microbiol Date: 2013-04-09 Impact factor: 3.715